Perry Premdas

Perry Premdas

Direktör/Styrelseledamot på
OPX Biotechnologies, Inc.
73 år
Process Industries
Consumer Non-Durables
Health Technology

Profil

Perry W.
Premdas
is currently a Director at OPX Biotechnologies, Inc. He previously served as an Independent Director at Balchem Corp.
from 2008 to 2023, and as a Director at Fresenius Kabi Pharmaceuticals Holding LLC from 2008 to 2011.
Mr. Premdas also held various Director positions at Ferro Corp., J.
M.
Huber Corp., and HNA Holdings, Inc. Additionally, he served as the Chief Financial Officer at Celanese AG from 1999 to 2004 and at Centeon LLC from 1997 to 1998.
Mr. Premdas received his undergraduate degree from Brown University and his MBA from Harvard Business School.

Aktiva positioner av Perry Premdas

FöretagPositionStart
Direktör/Styrelseledamot 2012-01-01

Tidigare kända positioner av Perry Premdas

FöretagPositionSlut
BALCHEM CORPORATION Direktör/Styrelseledamot 2023-06-22
COMPASS MINERALS INTERNATIONAL, INC. Direktör/Styrelseledamot 2015-05-01
Direktör/Styrelseledamot 2011-02-17
Finansdirektör/CFO 2004-01-01
Centeon LLC
Finansdirektör/CFO 1998-01-01
Se detaljerna i Perry Premdass erfarenhet

Perry Premdass utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

68

Första gradens relationer

11

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag11

Consumer Non-Durables

Process Industries

Process Industries

Consumer Non-Durables

Process Industries

Process Industries

Health Technology

Health Technology

Consumer Services

Centeon LLC

Consumer Services

  1. Börsen
  2. Insiders
  3. Perry Premdas